Desipramine

How Hard Is It to Find Desipramine in Stock?

Desipramine is not currently listed as an active shortage on the FDA Drug Shortage Database. However, it is not widely stocked at all pharmacies — particularly for less common strengths like 10 mg and 75 mg. As an older generic with declining prescription volume, pharmacies tend to keep minimal inventory, which can result in localized supply gaps and delays of 1–5 days while pharmacies reorder.

The most reliable approach is to call ahead before going to pick up your prescription, or to ask your pharmacist to place an advance order before you run out. Independent pharmacies often have more flexibility to stock and order less common generics than large chain pharmacies.

If you're struggling to locate desipramine, medfinder is a paid service that calls pharmacies near you on your behalf to find which ones have your specific dose in stock — and texts you the results. No hold music, no repeated explaining.

Who Can Prescribe Desipramine?

Desipramine is not a DEA-scheduled controlled substance, so there are no special prescribing restrictions. Any licensed prescriber with the appropriate state authorization can write a prescription for desipramine. The following provider types commonly prescribe it:

Psychiatrists — most commonly for treatment-resistant depression and psychiatric off-label uses

Primary care physicians (PCPs) and internists — for established patients and depression management

Neurologists — for neuropathic pain, postherpetic neuralgia, and fibromyalgia

Nurse practitioners (NPs) and physician assistants (PAs) — with full or supervised prescribing authority depending on the state

Gastroenterologists — for low-dose desipramine in IBS and functional GI disorders

Pain management specialists — for chronic neuropathic pain conditions

Because desipramine is not a controlled substance, it can be prescribed via telehealth without the in-person visit requirements that apply to Schedule II medications. Telehealth platforms that offer psychiatric or general medical prescribing can evaluate and prescribe desipramine in a single visit if clinically appropriate.

Is Desipramine a Controlled Substance?

No. Desipramine is not a DEA-scheduled controlled substance. It does not carry abuse potential, does not require special DEA registration to prescribe, and is not subject to the prescribing quantity or refill restrictions that apply to Schedule II–V medications.

Because it is not a controlled substance, desipramine can be prescribed via telemedicine without the in-person evaluation requirements that apply to stimulant ADHD medications or benzodiazepines. It can also be refilled with standard refill authorization (typically up to one year from the prescribing date, depending on state law).

While desipramine is not a controlled substance, it still requires a valid prescription from a licensed healthcare provider. It should not be shared with others, and the smallest practical quantity should be dispensed to patients with any history of suicidal ideation due to its significant overdose toxicity.

Common Side Effects of Desipramine

Desipramine has fewer anticholinergic and sedating side effects than most other TCAs, but still causes side effects that patients should be aware of:

Dry mouth

Constipation

Dizziness / orthostatic hypotension (particularly when standing)

Insomnia (activating rather than sedating)

Nausea and GI upset

Sweating (diaphoresis)

Tremors

Blurred vision

Sexual dysfunction (impaired arousal or orgasm)

Serious side effects requiring prompt medical attention:

Cardiac arrhythmias / QT prolongation / heart palpitations

Serotonin syndrome (agitation, fever, rapid heart rate, muscle rigidity)

Seizures

Angle-closure glaucoma (eye pain, sudden vision changes, redness)

Blood disorders (unusual bruising, bleeding, purple spots on skin)

Suicidal thoughts (especially in patients under 25 during initial months of treatment — FDA boxed warning)

Final Thoughts on Desipramine

Desipramine is a time-tested tricyclic antidepressant that remains a valuable option for patients who haven't responded to first-line treatments, and for specific conditions like neuropathic pain and ADHD where norepinephrine enhancement is clinically beneficial. While it requires careful monitoring due to its cardiac and overdose risk profile, it is generally well-tolerated — especially compared to other TCAs, since it has the fewest anticholinergic and sedating effects in its class.

The biggest practical challenge for many desipramine patients in 2026 is not clinical — it's finding the medication at a pharmacy. Desipramine's declining prescription volume means some pharmacies don't stock it reliably. Proactive refill habits, working with a trusted independent pharmacy, and using a 90-day mail-order supply are the best strategies for maintaining uninterrupted access.

If you're having trouble finding desipramine near you, medfinder can help. As a paid service, medfinder calls pharmacies in your area to find which ones have your specific medication and dose in stock, then texts you the results — saving you the time and frustration of calling around yourself.